As of 2025-07-08, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (84.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -102435.6%.
The range of the Relative Valuation is (71.25) - (83.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 29.0x | 26.6x |
| Forward P/E multiples | 24.6x - 40.7x | 32.1x |
| Fair Price | (71.25) - (83.93) | (84.94) |
| Upside | -85943.4% - -101215.3% | -102435.6% |
| Date | P/E |